We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MGA:NYSEMagna International, Inc. Analysis

Data as of 2026-05-22 - not real-time

$64.10

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Magna International (MGA) is trading at $64.1, comfortably above its 20‑day SMA of $61.76 and 50‑day SMA of $58.77, indicating short‑term bullish momentum, while still below the 200‑day SMA of $52.86, confirming a longer‑term uptrend. Technical signals are mixed: RSI sits at 59.9 (neutral), MACD histogram is slightly negative and flagged as bearish, and volume is on a decreasing trend, suggesting caution on immediate upside. The stock’s beta of 1.23 and 30‑day volatility of 38.9% point to higher price swings typical of the consumer‑cyclical auto‑parts sector. Fundamentally, MGA appears undervalued with a DCF fair value of $94.45, offering roughly a 7% upside, while the forward PE of 8.43 and forward EPS of $7.60 signal strong earnings growth ahead. Recent earnings have delivered a 58% YoY jump in adjusted EBIT and a 190‑bp margin expansion to 5.4%, reinforcing the earnings momentum highlighted in the latest news. The dividend yield of 3.14% is attractive, but an 82% payout ratio raises sustainability questions given a debt‑to‑equity of 54.6% and modest ROE of 5.97%. Overall, the combination of bullish price positioning, earnings beat expectations, and an attractive valuation makes MGA a compelling near‑term buy, while its cyclicality and leverage suggest a more measured stance for the longer horizon.
The upcoming Q1 earnings release, where consensus EPS is expected to rise 29.5% YoY, could serve as a catalyst, especially if the company continues to beat revenue and earnings estimates as it has 75% and 50% of the time respectively. Investors should weigh the upside from undervaluation and dividend income against the higher volatility, leverage, and sector‑specific risks before deciding on position sizing.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Price above 20‑day and 50‑day SMAs indicating bullish momentum
  • Upcoming earnings expected to beat consensus estimates
  • Attractive dividend yield despite high payout ratio

Medium Term

1–3 years
Positive
Model confidence: 9/10

Key Factors

  • Undervalued relative to DCF fair value with ~7% upside
  • Strong forward earnings growth (forward PE 8.43, forward EPS $7.60)
  • Margin expansion and robust cash flow supporting operations

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Cyclical exposure to the auto‑parts sector and high beta
  • Elevated debt levels and moderate ROE limiting upside
  • Sustainable dividend income balanced against payout sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth3.10%
Profit Margin1.58%
P/E Ratio27.0
ROE5.97%
ROA4.41%
Debt/Equity54.60
P/B Ratio1.5
Op. Cash Flow$4.2B
Free Cash Flow$2.1B

Technical Analysis

TrendBullish
RSI59.9
Support$57.48
Resistance$64.62
MA 20$61.76
MA 50$58.77
MA 200$52.86
MACDBearish
VolumeDecreasing
Fear & Greed Index91.79

Valuation

Fair Value$94.45
Target Price$68.61
Upside/Downside7.04%
GradeUndervalued
TypeBlend
Dividend Yield3.14%

Risk Assessment

Beta1.23
Volatility38.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.